Publications
38
Citations
553
Est. group size
~14
Recurring co-author estimate
Active years
16
Publishing since 2011
This research record covers work on cancer genetics and molecular biology, including CRISPR/Cas9 genome-editing techniques, gene-essentiality screening in liver cancer (hepatocellular carcinoma), and studies of proteins involved in cell survival and programmed cell death. Related work also touches on cancer diagnostics using genomic sequencing and clinical studies of tumor treatment outcomes. Prospective students would be working in an area that blends molecular cancer biology, genome-editing tools, and translational oncology research.
Publication output has been variable but shows an increase in recent years, rising from about 1-3 papers annually in the early 2020s to 4-7 per year from 2024 onward.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The Role of the Novel Lupus Antigen, Acheron, in Moderating Life and Death Decisions
ScholarWorks@UMassAmherst (University of Massachusetts Amherst) · 2021
- Acheron/Larp6 Is a Survival Protein That Protects Skeletal Muscle From Programmed Cell Death During Development
Frontiers in Cell and Developmental Biology · 2020
- Cytologically targeted next-generation sequencing: a synergy for diagnosing urothelial carcinoma
Journal of the American Society of Cytopathology · 2020
- Depletion of TRRAP Induces p53‐Independent Senescence in Liver Cancer by Down‐Regulating Mitotic Genes
Hepatology · 2019
- CRISPR-SONIC: targeted somatic oncogene knock-in enables rapid in vivo cancer modeling
Genome Medicine · 2019
- Real-time imaging of integrin β4 dynamics using a reporter cell line generated by Crispr/Cas9 genome editing
Journal of Cell Science · 2019
- Integrating CRISPR screening with tumor genomic analyses to identify therapeutic targets in hepatocellular carcinomas (HCC) independent of P53.
Journal of Clinical Oncology · 2019
- Identification of Essential Genes in Hepatocellular Carcinomas using CRISPR Screening
The Journal of the American Medical Association (JAMA) Network (American Medical Association) · 2019
- Abstract 3374: CRISPR/Cas9 mediated genome editing induces exon skipping by alternative splicing or exon deletion
Cancer Research · 2018
- CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
Genome biology · 2017
- Treatment and prognostic factors of patients with thymic epithelial tumors at first recurrence or progression
Future Oncology · 2017
- OA18.06 Treatment, Outcome and Prognostic Factors of Patients with Thymic Epithelial Tumors at First Recurrence
Journal of Thoracic Oncology · 2017
- Additional file 2: of CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
Figshare · 2017
- Additional file 1: of CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
Figshare · 2017
- Additional file 1: of CRISPR/Cas9-mediated genome editing induces exon skipping by alternative splicing or exon deletion
Figshare · 2017
- Journal of Clinical Oncology×9
- Figshare×3
- Cancers×2
- International Journal of Molecular Sciences×2
- Cancer Research×2
- Susan Tsai
Medicine · The Ohio State University
- Susan Tsai
Medicine · The Ohio State University
- Ashwini Esnakula
Medicine · The Ohio State University
- Susan Tsai
Medicine · The Ohio State University
- Amir Sara
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile